Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3500 participants
OBSERVATIONAL
2007-11-30
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct
NCT02067091
Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment
NCT00968383
Cohort of STEMI Patients
NCT02822638
Occluded Artery Trial (OAT)
NCT00004562
Stent Thrombosis In Acute Coronary Syndromes
NCT00931502
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Study design: individual patient data meta-analysis
* Data sources: European Centre performing human cardiac stem cell therapy have been contacted calling for participation.
* Methods: Individual data gathering and entering into the database for a pooled analysis. The meta-analysis will be done in line with recommendation from the Cochrane Collaboration and the Quality of Reporting of Meta-analyses guidelines with Review Manager 5.0. Fixed-effect model will be used.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myocardial infarction
Patients with post-myocardial infarction receiving cell therapy either intracoronarily or intramyocardial
cell therapy
Ischemic cardiomyopathy
Patients with ischemic cardiomyopathy treated with cell therapy either intracoronarily or intramyocardial
cell therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cell therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Oslo University Hospital
OTHER
Medical University of Silesia
OTHER
Hannover Medical School
OTHER
VZW Cardiovascular Research Center Aalst
OTHER
Cedars-Sinai Medical Center
OTHER
Johann Wolfgang Goethe University Hospital
OTHER
University of Ulm
OTHER
Military Medical Academy, Belgrade, Serbia
OTHER
Novosibirsk Scientific Research Institute for Circulatory Pathology
OTHER
Rigshospitalet, Denmark
OTHER
Asklepios Kliniken Hamburg GmbH
OTHER
Leiden University Medical Center
OTHER
University of Debrecen
OTHER
University of Targu Mures, Romania
OTHER
University Clinic for Cardiology, Skopje, Republic of Macedonia
UNKNOWN
State Health Center, Hungary
OTHER
Karolinska Institutet
OTHER
University of Zurich
OTHER
University of Oulu
OTHER
Odense University Hospital
OTHER
Minneapolis Heart Institute
OTHER
The University of Texas Health Science Center, Houston
OTHER
Klinik Hirslanden, Zurich
OTHER
University Hospital, Toulouse
OTHER
Heinrich-Heine University, Duesseldorf
OTHER
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mariann Gyongyosi
MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariann Gyongyosi, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gyongyosi M, Wojakowski W, Lemarchand P, Lunde K, Tendera M, Bartunek J, Marban E, Assmus B, Henry TD, Traverse JH, Moye LA, Surder D, Corti R, Huikuri H, Miettinen J, Wohrle J, Obradovic S, Roncalli J, Malliaras K, Pokushalov E, Romanov A, Kastrup J, Bergmann MW, Atsma DE, Diederichsen A, Edes I, Benedek I, Benedek T, Pejkov H, Nyolczas N, Pavo N, Bergler-Klein J, Pavo IJ, Sylven C, Berti S, Navarese EP, Maurer G; ACCRUE Investigators. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015 Apr 10;116(8):1346-60. doi: 10.1161/CIRCRESAHA.116.304346. Epub 2015 Feb 19.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MUW - Meta
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.